HRT Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,030
Closed -$4.04M 3211
2024
Q4
$4.04M Sell
10,030
-33,267
-77% -$13.4M 0.02% 387
2024
Q3
$20.1M Sell
43,297
-80,212
-65% -$37.3M 0.1% 110
2024
Q2
$57.9M Buy
+123,509
New +$57.9M 0.32% 38
2024
Q1
Sell
-7,948
Closed -$3.23M 2981
2023
Q4
$3.23M Buy
7,948
+5,406
+213% +$2.2M 0.02% 430
2023
Q3
$883K Sell
2,542
-1,272
-33% -$442K 0.01% 961
2023
Q2
$1.34M Buy
+3,814
New +$1.34M 0.01% 725
2022
Q2
Hold
0
3589
2022
Q1
Sell
-63,603
Closed -$14M 3620
2021
Q4
$14M Buy
+63,603
New +$14M 0.08% 118
2021
Q3
Sell
-6,834
Closed -$1.38M 3555
2021
Q2
$1.38M Sell
6,834
-25,442
-79% -$5.13M 0.01% 783
2021
Q1
$6.94M Buy
+32,276
New +$6.94M 0.07% 178
2019
Q4
Sell
-9,191
Closed -$1.56M 1586
2019
Q3
$1.56M Buy
+9,191
New +$1.56M 0.07% 179
2019
Q2
Sell
-7,768
Closed -$1.43M 897
2019
Q1
$1.43M Buy
+7,768
New +$1.43M 0.22% 56
2018
Q3
Sell
-5,368
Closed -$912K 463
2018
Q2
$912K Buy
5,368
+3,443
+179% +$585K 0.33% 41
2018
Q1
$313K Buy
+1,925
New +$313K 0.15% 129
2015
Q4
Sell
-2,584
Closed -$269K 119
2015
Q3
$269K Buy
+2,584
New +$269K 0.23% 58